Novartis R&D Chief Tsai On 2019 Goals, Priorities, BD And Digital Advances

R&D head John Tsai spoke with Scrip about culture change at Novartis as it moves toward advanced therapy platforms and embraces digital technologies, and offered a peek into what’s in store for R&D in 2019 and beyond.